Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0000905148-24-000445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-06 | 2024-02-02+ | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | S - Sale | $1.14 | -52.9K | 2.07M | -2% | -$60.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-05 | S | D | 30,545 | $1.14 | 2,036,629 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-02 | S | D | 22,349 | $1.13 | 2,067,174 | D | — | — | (F2) The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $1.13 to $1.135. Upon request, the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission staff, full information regarding the shares sold at each such separate price. |